Truist Financial
VRTX icon

Truist Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$93.5M Sell
210,089
-13,881
-6% -$6.18M 0.14% 147
2025
Q1
$109M Buy
223,970
+12,166
+6% +$5.9M 0.17% 129
2024
Q4
$85.3M Buy
211,804
+1,885
+0.9% +$759K 0.13% 144
2024
Q3
$97.6M Sell
209,919
-8,722
-4% -$4.06M 0.15% 129
2024
Q2
$102M Sell
218,641
-4,470
-2% -$2.1M 0.16% 136
2024
Q1
$93.3M Sell
223,111
-2,245
-1% -$938K 0.14% 146
2023
Q4
$91.7M Sell
225,356
-1,707
-0.8% -$695K 0.15% 139
2023
Q3
$79M Buy
227,063
+58,219
+34% +$20.2M 0.13% 157
2023
Q2
$59.4M Buy
168,844
+8,141
+5% +$2.86M 0.1% 193
2023
Q1
$50.6M Sell
160,703
-10,741
-6% -$3.38M 0.09% 216
2022
Q4
$49.5M Buy
171,444
+62,866
+58% +$18.2M 0.09% 211
2022
Q3
$31.4M Buy
108,578
+1,741
+2% +$504K 0.06% 279
2022
Q2
$30.1M Sell
106,837
-4,137
-4% -$1.17M 0.06% 304
2022
Q1
$29M Buy
110,974
+26,836
+32% +$7M 0.05% 331
2021
Q4
$18.5M Buy
84,138
+2,887
+4% +$634K 0.03% 450
2021
Q3
$14.7M Buy
81,251
+43,511
+115% +$7.89M 0.02% 500
2021
Q2
$7.61M Buy
37,740
+85
+0.2% +$17.1K 0.01% 728
2021
Q1
$8.09M Sell
37,655
-1,866
-5% -$401K 0.01% 671
2020
Q4
$9.34M Sell
39,521
-2,794
-7% -$660K 0.02% 618
2020
Q3
$11.5M Buy
42,315
+2,825
+7% +$769K 0.03% 514
2020
Q2
$11.5M Buy
39,490
+4,584
+13% +$1.33M 0.03% 499
2020
Q1
$8.31M Sell
34,906
-265
-0.8% -$63.1K 0.02% 548
2019
Q4
$7.7M Buy
35,171
+25,577
+267% +$5.6M 0.02% 636
2019
Q3
$1.63M Buy
9,594
+83
+0.9% +$14.1K 0.03% 385
2019
Q2
$1.75M Sell
9,511
-172
-2% -$31.6K 0.03% 373
2019
Q1
$1.78M Sell
9,683
-94
-1% -$17.3K 0.03% 367
2018
Q4
$1.62M Sell
9,777
-685
-7% -$114K 0.03% 369
2018
Q3
$2.02M Buy
10,462
+104
+1% +$20.1K 0.04% 364
2018
Q2
$1.76M Sell
10,358
-1,067
-9% -$181K 0.03% 378
2018
Q1
$1.86M Buy
11,425
+227
+2% +$37K 0.04% 374
2017
Q4
$1.68M Buy
11,198
+92
+0.8% +$13.8K 0.03% 398
2017
Q3
$1.69M Sell
11,106
-203
-2% -$30.9K 0.03% 381
2017
Q2
$1.46M Sell
11,309
-2,020
-15% -$260K 0.03% 403
2017
Q1
$1.46M Buy
13,329
+5,223
+64% +$571K 0.03% 413
2016
Q4
$597K Buy
8,106
+45
+0.6% +$3.31K 0.01% 558
2016
Q3
$703K Sell
8,061
-340
-4% -$29.7K 0.01% 530
2016
Q2
$723K Buy
8,401
+308
+4% +$26.5K 0.02% 530
2016
Q1
$644K Buy
8,093
+67
+0.8% +$5.33K 0.02% 503
2015
Q4
$1.01M Buy
8,026
+4,566
+132% +$575K 0.03% 413
2015
Q3
$360K Buy
3,460
+1,164
+51% +$121K 0.01% 624
2015
Q2
$284K Sell
2,296
-45
-2% -$5.57K 0.01% 669
2015
Q1
$276K Sell
2,341
-1,725
-42% -$203K 0.01% 684
2014
Q4
$483K Sell
4,066
-272
-6% -$32.3K 0.01% 519
2014
Q3
$487K Sell
4,338
-214
-5% -$24K 0.01% 501
2014
Q2
$431K Sell
4,552
-515
-10% -$48.8K 0.01% 543
2014
Q1
$358K Buy
5,067
+290
+6% +$20.5K 0.01% 583
2013
Q4
$355K Sell
4,777
-713
-13% -$53K 0.01% 584
2013
Q3
$416K Buy
5,490
+181
+3% +$13.7K 0.01% 526
2013
Q2
$425K Buy
+5,309
New +$425K 0.02% 513